<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04649970</url>
  </required_header>
  <id_info>
    <org_study_id>U23459</org_study_id>
    <nct_id>NCT04649970</nct_id>
  </id_info>
  <brief_title>Antegrade Double-J Stent Placement for the Treatment of Malignant Obstructive Uropathy</brief_title>
  <official_title>Antegrade Double-J Stent Placement for the Treatment of Malignant Obstructive Uropathy: a Single Center Experience</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Université de Sousse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Université de Sousse</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ureteral double- J stent is usually inserted by retrograde approach for the treatment of&#xD;
      obstructed upper urinary tract. The antegrade approach, can a suitable alternative in certain&#xD;
      situations without the need for general or spinal anesthesia. The present study demonstrates&#xD;
      the indications, success rate, and complications of this approach in the treatment of&#xD;
      malignant obstructive uropathy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Data of consecutive patients in whom antegrade ureteral stent¬ing was performed between&#xD;
      January 2013 and February 2020 were retrospectively analysed using patient records and&#xD;
      radiology reports. A total of 174 patients (sexe ratio = 0.51, age range 9-91 years; mean&#xD;
      age, 54 years) were included in the study.&#xD;
&#xD;
      Ureteral obstruction was caused by bladder cancer (n=92), uterin cancer (n=31), prostate&#xD;
      cancer (n=28), colorectal cancer (n= 15) and retroperitoneal tumor (n= 8) (Table 1).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2013</start_date>
  <completion_date type="Actual">February 2, 2020</completion_date>
  <primary_completion_date type="Actual">June 29, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>number of patient having Antegrade double-J stent placement for the treatment of malignant obstructive uropathy</measure>
    <time_frame>7 years</time_frame>
    <description>double j stent placement succeed or failed</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">174</enrollment>
  <condition>Urologic Neoplasms</condition>
  <arm_group>
    <arm_group_label>malignant uropathy</arm_group_label>
    <description>Antegrade double-J stent</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Antegrade double-J stent</intervention_name>
    <description>After exchanging the nephrostomy catheter over the J-tipped guidewire, 5 F multipurpose (45° tip) diagnostic vascular catheter was inserted. Once the pelvi¬ureteric junction was crossed and the ureter accessed, a straight hydrophilic guidewire and a catheter were used. Then, the cath-eter was advanced into the bladder over the wire, this guidewire was exchanged for an ultra-stiff guidewire, an 8 or 10 F double J ureteral stent was placed over the guidewire, and the safety kit of the stent was removed. A final fluoroscopic image was stored for correcting the stent position.</description>
    <arm_group_label>malignant uropathy</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        A total of 174 patients (sexe ratio = 0.51, age range 9-91 years; mean age, 54 years) were&#xD;
        included in the study.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  malignant uropathy obstruction&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  benign uropathy obstruction&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>ghaassen tlili, PROFESSOR</last_name>
    <role>Study Director</role>
    <affiliation>university of sousse</affiliation>
  </overall_official>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>November 24, 2020</study_first_submitted>
  <study_first_submitted_qc>November 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 2, 2020</study_first_posted>
  <last_update_submitted>December 2, 2020</last_update_submitted>
  <last_update_submitted_qc>December 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Université de Sousse</investigator_affiliation>
    <investigator_full_name>ammar houssem</investigator_full_name>
    <investigator_title>clinical professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urologic Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

